Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Demographics of Hepatitis C in Southwest Ohio (2010 to 2015).

Woltmann J, Burke P, Brady R, Blackard JT.

Hepat Mon. 2016 Jul 20;16(8):e37904. eCollection 2016 Aug.

2.

Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination.

Hoft DF, Lottenbach K, Goll JB, Hill H, Winokur PL, Patel SM, Brady RC, Chen WH, Edwards K, Creech CB, Frey SE, Blevins TP, Salomon R, Belshe RB.

J Infect Dis. 2016 Oct 1;214(7):1020-9. doi: 10.1093/infdis/jiw310. Epub 2016 Jul 20.

PMID:
27443611
3.

Interferon-Free Treatments for Chronic Hepatitis C Genotype 1 Infection.

FakhriRavari A, Malakouti M, Brady R.

J Clin Transl Hepatol. 2016 Jun 28;4(2):97-112. doi: 10.14218/JCTH.2016.00007. Epub 2016 Jun 15. Review.

4.

PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation.

Coomarasamy A, Williams H, Truchanowicz E, Seed PT, Small R, Quenby S, Gupta P, Dawood F, Koot YE, Atik RB, Bloemenkamp KW, Brady R, Briley A, Cavallaro R, Cheong YC, Chu J, Eapen A, Essex H, Ewies A, Hoek A, Kaaijk EM, Koks CA, Li TC, MacLean M, Mol BW, Moore J, Parrott S, Ross JA, Sharpe L, Stewart J, Trépel D, Vaithilingam N, Farquharson RG, Kilby MD, Khalaf Y, Goddijn M, Regan L, Rai R.

Health Technol Assess. 2016 May;20(41):1-92. doi: 10.3310/hta20410.

5.

Adolescent Vaccination Strategies: Interventions to Increase Coverage.

Lehmann CE, Brady RC, Battley RO, Huggins JL.

Paediatr Drugs. 2016 Aug;18(4):273-85. doi: 10.1007/s40272-016-0177-1. Review.

PMID:
27146296
6.

Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor.

Chen WH, Cohen MB, Kirkpatrick BD, Brady RC, Galloway D, Gurwith M, Hall RH, Kessler RA, Lock M, Haney D, Lyon CE, Pasetti MF, Simon JK, Szabo F, Tennant S, Levine MM.

Clin Infect Dis. 2016 Jun 1;62(11):1329-1335. doi: 10.1093/cid/ciw145. Epub 2016 Mar 21.

7.

The Validation of a Case-Based, Cumulative Assessment and Progressions Examination.

Brady RL, Coker AO, Copeland JT, Gottlieb HB, Horlen C, Smith HE, Urteaga EM, Ramsinghani S, Zertuche A, Maize D.

Am J Pharm Educ. 2016 Feb 25;80(1):9. doi: 10.5688/ajpe8019.

8.

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine.

Mbawuike IN, Atmar RL, Patel SM, Corry DB, Winokur PL, Brady RC, Chen WH, Edwards KM, Creech CB, Walter EB Jr, Frey SE, Belshe RB, Goll JB, Hill H, Keitel WA.

Vaccine. 2016 Jan 20;34(4):547-54. doi: 10.1016/j.vaccine.2015.11.055. Epub 2015 Dec 4.

9.

Case 1: Clavicular Pain of 2 Months' Duration in a 9-year-old Girl.

Brady RC, Crawford AH.

Pediatr Rev. 2015 Dec;36(12):545-7. doi: 10.1542/pir.36-12-545. No abstract available.

PMID:
26628735
10.

A Randomized Trial of Progesterone in Women with Recurrent Miscarriages.

Coomarasamy A, Williams H, Truchanowicz E, Seed PT, Small R, Quenby S, Gupta P, Dawood F, Koot YE, Bender Atik R, Bloemenkamp KW, Brady R, Briley AL, Cavallaro R, Cheong YC, Chu JJ, Eapen A, Ewies A, Hoek A, Kaaijk EM, Koks CA, Li TC, MacLean M, Mol BW, Moore J, Ross JA, Sharpe L, Stewart J, Vaithilingam N, Farquharson RG, Kilby MD, Khalaf Y, Goddijn M, Regan L, Rai R.

N Engl J Med. 2015 Nov 26;373(22):2141-8. doi: 10.1056/NEJMoa1504927.

11.

Nocardia farcinica Meningitis Masquerading as Central Nervous System Metastasis in a Child With Cerebellar Pilocytic Astrocytoma.

Davis J, Kreppel AJ, Brady RC, Jones B, Stevenson CB, Fouladi M, Hummel TR.

J Pediatr Hematol Oncol. 2015 Aug;37(6):482-5. doi: 10.1097/MPH.0000000000000360.

PMID:
26181420
12.

RNA-Seq Analysis of the Host Response to Staphylococcus aureus Skin and Soft Tissue Infection in a Mouse Model.

Brady RA, Bruno VM, Burns DL.

PLoS One. 2015 Apr 22;10(4):e0124877. doi: 10.1371/journal.pone.0124877. eCollection 2015.

13.

Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine.

Winokur PL, Patel SM, Brady R, Chen WH, El-Kamary SS, Edwards K, Creech CB, Frey S, Keitel WA, Belshe R, Walter E, Bellamy A, Hill H.

J Infect Dis. 2015 Aug 15;212(4):525-30. doi: 10.1093/infdis/jiv087. Epub 2015 Feb 23.

14.

Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC.

Romeo MM, Ko B, Kim J, Brady R, Heatley HC, He J, Harrod CK, Barnett B, Ratner L, Lairmore MD, Martinez E, Lüscher B, Robson CN, Henriksson M, Harrod R.

Virology. 2015 Feb;476:271-88. doi: 10.1016/j.virol.2014.12.008. Epub 2015 Jan 5.

15.

Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States children.

Brady RC, Hu W, Houchin VG, Eder FS, Jackson KC, Hartel GF, Sawlwin DC, Albano FR, Greenberg M.

Vaccine. 2014 Dec 12;32(52):7141-7. doi: 10.1016/j.vaccine.2014.10.024. Epub 2014 Oct 29.

PMID:
25454878
16.

Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.

Frey SE, Bernstein DI, Brady RC, Keitel WA, El Sahly H, Rouphael NG, Mulligan MJ, Atmar RL, Edupuganti S, Patel SM, Dickey M, Graham I, Anderson EL, Noah DL, Hill H, Wolff M, Belshe RB.

Vaccine. 2015 Jan 1;33(1):163-73. doi: 10.1016/j.vaccine.2014.10.083. Epub 2014 Nov 11.

17.

Operation Donate: defining the value of redispensing medications donated by individuals.

Glanville M, Brady R, Miller S.

J Am Pharm Assoc (2003). 2014 Sep-Oct;54(5):542-7. doi: 10.1331/JAPhA.2014.11101.

PMID:
25216885
18.
19.

Immunogenicity analysis of Staphylococcus aureus clumping factor A genetic variants.

Brady RA, Mocca CP, Burns DL.

Clin Vaccine Immunol. 2013 Aug;20(8):1338-40. doi: 10.1128/CVI.00275-13. Epub 2013 Jun 26.

20.

Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.

Brady RA, Mocca CP, Prabhakara R, Plaut RD, Shirtliff ME, Merkel TJ, Burns DL.

PLoS One. 2013 Apr 29;8(4):e63040. doi: 10.1371/journal.pone.0063040. Print 2013.

Supplemental Content

Loading ...
Support Center